Impact of wearable technology on Chronic respiratory diseases: asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD)

Unfortunately chronic respiratory diseases including asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD) affect up to one billion patients globally. However there is a new sign of hope with new wearable technology that allows clinicians to monitor patients’ vitals remotely .ABI Research forecasts device connectivity will drive new chronic respiratory disease wearable form factors, with shipments to grow from three million shipments in 2017 to 12 million in 2022.

The firm also forecasts that, the U.S. will spend the most on chronic respiratory disease wearables, accounting for $6 million in 2022 of $21 million in global market revenues. Following the U.S., Europe and the Asia Pacific will also see high adoption rates. As the nascent market gains momentum, the devices will gradually shift from wireless finger-clips to wrist-worn devices.